Diabetes can cause severe health problems such as diabetic kidney disease (DKD) as well as end-stage kidney disease. There are approximately 34.2 million people with diabetes within the U.S. and this has been a focal point for innovative researchers to increase the efficacy of diagnostics and therapeutics.
The use of nanotechnology for the advancement of theranostics has become a key driver in developing innovative approaches. These can be used to overcome limitations within current standards of practice and procedures, such as biopsy and histopathological evaluation.
The current standard imaging technique for detecting diabetic kidney disease (DKD) requires the use of CT and MRI scans. Nanotechnology can be beneficial for this purpose and can be used to improve the imaging of kidneys. This is due to the benefits of being within a nanoscale, such as a high surface area and high reactivity.
Nanotechnology has shown immense benefit with versatile use within a range of applications, and this has furthered its advancement for different disorders. Nanoparticles can be used as enhancement tools for imaging, enabling them to be an alternative to potentially toxic contrast agents that are used within the body.
Name of Author: Marzia Khan And Megan Craig